# Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

> **NCT00691717** · PHASE2,PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 201 (actual)

## Conditions studied

- Open-angle Glaucoma
- Oular Hypertension

## Interventions

- **DRUG:** Anecortave Acetate Sterile Suspension, 30 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 60 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 75 mg/mL
- **OTHER:** Anecortave Acetate Vehicle

## Key facts

- **NCT ID:** NCT00691717
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2012-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691717, "Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00691717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*